Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients
Clinical trial NCT03094845 · COMPLETED
Trial details
- NCT number
- NCT03094845
- Sponsor
- ASIT Biotech S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-28
- Primary completion
- 2017-01-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.